Neuro-Active Peptides TECHNOLOGY

The Team MEET US

The Science PIPELINE

Development Technology

Protagenic Therapeutics, Inc.

First-in-Class Neuropeptides

home-box-1-350x200

Our Mission

To develop novel compounds with breakthrough treatment potential for stress-related disorders

Stress-related Disorders

home-box-2-350x200

Our Focus

The initial target indications for our lead compound (PT00114) are PTSD and Drug & Alcohol Addiction

Platform Technology

home-box3-350x200

Family of Compounds

Teneurin c-terminal associated peptides (TCAP’s) have the potential to become first-in-class pharmaceutical agents addressing a variety of unmet clinical needs

An innovative, safe and effective treatment for PTSD and Addiction, using neuropeptide hormones to control stress response.